Literature DB >> 27609790

Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.

Jacob H Rasmussen1,2, Martin Nørgaard3,4, Adam E Hansen3, Ivan R Vogelius5, Marianne C Aznar5, Helle H Johannesen3, Junia Costa3, Astrid M E Engberg3, Andreas Kjær3,6, Lena Specht5, Barbara M Fischer3.   

Abstract

The purpose of this study was to investigate and assess the correlation and reproducibility of multiparametric imaging in head and neck cancer patients.
METHODS: Twenty-one patients were included in this prospective scan-rescan study. All patients were scanned twice on an integrated PET and MRI scanner. Gross tumor volumes were defined on T2-weighted MR images, and volumes of interest were defined on diffusion-weighted MRI and 18F-FDG PET (VOIDWI, VOIPET). Overlap between volumes was assessed as a percentwise overlap. 18F-FDG uptake and diffusion were measured using SUV and apparent diffusion coefficient, and correlation was tested across and within patients and as a voxel-by-voxel analysis.
RESULTS: Seventeen patients were available for correlation analysis, and 12 patients were available for assessment of tumor overlap. The median tumor overlap between VOIDWI and VOIPET was 82% (VOIDWI in VOIPET) and 62% (VOIPET in VOIDWI) on scan 1 and scan 2, respectively. Across patients, the correlation between SUV and apparent diffusion coefficient was weak and nonsignificant. However, in individual patients a weak but significant correlation was identified on a voxel-by-voxel basis.
CONCLUSION: In multiparametric imaging with the integrated PET/MR scanner, the VOIs from DWI and 18F-FDG PET were both within the target volume for radiotherapy and overlapped substantially although not completely. No correlation between 18F-FDG uptake and DWI could be found across patients, but within individual patients a statistically significant, but weak, voxel-by-voxel correlation was found. The findings suggest that information on glucose uptake and diffusion coefficient carries complementary information of interest that may be relevant for radiotherapy treatment planning.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PET/MRI; head and neck; head and neck cancer; multiparametric imaging; oncology; other

Mesh:

Year:  2016        PMID: 27609790     DOI: 10.2967/jnumed.116.180091

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Extracting and Selecting Robust Radiomic Features from PET/MR Images in Nasopharyngeal Carcinoma.

Authors:  Pengfei Yang; Lei Xu; Zuozhen Cao; Yidong Wan; Yi Xue; Yangkang Jiang; Eric Yen; Chen Luo; Jing Wang; Yi Rong; Tianye Niu
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

2.  Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.

Authors:  Ashok J Theruvath; Florian Siedek; Anne M Muehe; Jordi Garcia-Diaz; Julian Kirchner; Ole Martin; Michael P Link; Sheri Spunt; Allison Pribnow; Jarrett Rosenberg; Ken Herrmann; Sergios Gatidis; Jürgen F Schäfer; Michael Moseley; Lale Umutlu; Heike E Daldrup-Link
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

Review 3.  Recent advances in MRI of the head and neck, skull base and cranial nerves: new and evolving sequences, analyses and clinical applications.

Authors:  Philip Touska; Steve E J Connor
Journal:  Br J Radiol       Date:  2019-09-24       Impact factor: 3.039

4.  Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup.

Authors:  Kerstin Zwirner; Daniela Thorwarth; René M Winter; Stefan Welz; Jakob Weiss; Nina F Schwenzer; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Daniel Zips; Sergios Gatidis
Journal:  Strahlenther Onkol       Date:  2018-03-21       Impact factor: 3.621

5.  Whole-Body MRI Is an Effective Imaging Modality for Hematological Malignancy Treatment Response Assessment: A Systematic Review and Meta-Analysis.

Authors:  Guisen Lin; Xiaodan Zong; Yaowen Li; Weiting Tan; Weisheng Sun; Siqi Zhang; Yungen Gan; Hongwu Zeng
Journal:  Front Oncol       Date:  2022-02-18       Impact factor: 6.244

6.  Correlation between Tissue Cellularity and Metabolism Represented by Diffusion-Weighted Imaging (DWI) and 18F-FDG PET/MRI in Head and Neck Cancer (HNC).

Authors:  Omar Freihat; Tóth Zoltán; Tamas Pinter; András Kedves; Dávid Sipos; Imre Repa; Árpád Kovács; Cselik Zsolt
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

7.  Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading.

Authors:  Leonard Leifels; Sandra Purz; Patrick Stumpp; Stefan Schob; Hans Jonas Meyer; Thomas Kahn; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2017-10-19       Impact factor: 3.161

Review 8.  Quantitative imaging for radiotherapy purposes.

Authors:  Oliver J Gurney-Champion; Faisal Mahmood; Marcel van Schie; Robert Julian; Ben George; Marielle E P Philippens; Uulke A van der Heide; Daniela Thorwarth; Kathrine R Redalen
Journal:  Radiother Oncol       Date:  2020-02-27       Impact factor: 6.280

9.  Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.

Authors:  René M Winter; Sara Leibfarth; Holger Schmidt; Kerstin Zwirner; David Mönnich; Stefan Welz; Nina F Schwenzer; Christian la Fougère; Konstantin Nikolaou; Sergios Gatidis; Daniel Zips; Daniela Thorwarth
Journal:  Radiother Oncol       Date:  2018-05-07       Impact factor: 6.280

10.  Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne Kathrin Höhn; Osama Sabri; Sandra Purz
Journal:  Transl Oncol       Date:  2018-09-18       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.